Compare KWR & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KWR | BHC |
|---|---|---|
| Founded | 1918 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.5B |
| IPO Year | 1985 | N/A |
| Metric | KWR | BHC |
|---|---|---|
| Price | $143.82 | $6.93 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $149.25 | $8.67 |
| AVG Volume (30 Days) | 136.7K | ★ 2.8M |
| Earning Date | 10-30-2025 | 10-29-2025 |
| Dividend Yield | ★ 1.40% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.97 |
| Revenue | $1,864,242,000.00 | ★ $10,029,000,000.00 |
| Revenue This Year | $3.44 | $6.81 |
| Revenue Next Year | $4.15 | $4.11 |
| P/E Ratio | ★ N/A | $7.11 |
| Revenue Growth | 0.08 | ★ 5.86 |
| 52 Week Low | $95.91 | $4.25 |
| 52 Week High | $148.80 | $8.69 |
| Indicator | KWR | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 61.80 | 55.69 |
| Support Level | $136.34 | $6.70 |
| Resistance Level | $146.16 | $7.07 |
| Average True Range (ATR) | 4.45 | 0.27 |
| MACD | 0.77 | -0.01 |
| Stochastic Oscillator | 81.78 | 30.90 |
Quaker Houghton manufactures and sells a variety of industrial process fluids. The product portfolio of the company includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids and surface treatment chemicals. The geographic segments of the company include America, EMEA, Asia/Pacific, and Global Specialty Businesses. The majority of the revenue is earned from America.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.